











National Enteric Disease Surveillance: Shiga toxin-producing 
Escherichia coli (STEC) Annual Report, 2014 
The Laboratory-based Enteric Disease Surveillance (LEDS) system contributes to the understanding of human 
Shiga toxin-producing Escherichia coli (STEC) in the United States by collecting reports of infections submitted 
by state and regional public health laboratories.1 Reporting to LEDS is voluntary; the number of laboratories 
submitting reports varies somewhat from year to year, although almost all public health laboratories report 
every year.  Occasionally, more than one isolate is reported from a single episode of infection in a person; this 
report includes only one isolate of a given STEC serogroup per person within a 30-day period. 
An overview of surveillance methods and systems for Shiga toxin-producing Escherichia coli (STEC) infections 
is available at http://www.cdc.gov/ncezid/dfwed/PDFs/national-stec-surveillance-overiew-508c.pdf (1).
Data in this report are current as of February 8, 2017.
Summary
 ● In 2014, 51 state and regional public health laboratories reported 4,437 cases of culture-confirmed Shiga 
toxin-producing Escherichia coli (STEC) infections and 999 STEC infections of unknown serogroup to LEDS, 
3% fewer and 1% more than in 2013, respectively. 
 ● Whereas incidence of infection due to non-O157 serogroups continued to rise in 2014 (0.79 cases per 
100,000 population), serogroup O157 infection incidence continued to decline (0.60 cases per 100,000 
population in 2014), and overall national incidence of culture-confirmed STEC continued to decrease (1.39 
cases per 100,000 population in 2014).
 ● Children 1–4 years old had the highest incidence of infection of all age groups for both O157 and 
non-O157 serogroups.
 ● Infants (<1 year old) had the largest difference in incidence between O157 and non-O157 serogroups 
of all age groups (1.19 vs. 1.97 cases per 100,000 population for girls and 0.69 vs. 2.18 cases per 100,000 
population for boys).
 ● At least half of states in the Midwest and West regions2 had incidence above the national average for 
culture-confirmed infection due to O157 and non-O157 serogroups (including IA, MN, MO, ND, SD, and WI 
in the Midwest and CO, HI, ID, MT, NM, OR, UT, WA, and WY in the West)
 ● The largest percentages of infections for both O157 and non-O157 serogroups were reported in the 
summer months.
1The practice of testing diarrheal stools for Shiga toxin without concomitant bacterial culture and serotyping has increased in recent years (2). The LEDS 
system is unable to differentiate reports of culture-confirmed STEC infection of unknown serogroup from reports of STEC diagnosed only by non-
culture methods.
2Geographic regions in this report are consistent with those defined by the United States Census Bureau (https://www2.census.gov/geo/pdfs/maps-
data/maps/reference/us_regdiv.pdf )
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Figure 1. Incidence rate of human Shiga toxin-producing Escherichia coli (STEC) infection reported to LEDS, by 
serogroup and year, United States, 1996–20141  
1 The “Total” category includes culture-confirmed infections of serogroup O157, non-O157 serogroups, and rough isolates.
2 When isolates are rough, the O group is not expressed and cannot be determined by phenotypic methods. These isolates can be O157 or non-O157.
3 The “Unknown” category includes cases diagnosed by culture-based methods where an isolate was never serogrouped and may also include cases 
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Table 1a. Culture-confirmed human STEC infections 
reported to LEDS, with the 10 most frequently reported 
serogroups listed individually, United States, 2014 




1 O157 1,919 43.2 0.60
2 O26 722 16.3 0.23
3 O103 631 14.2 0.20
4 O111 501 11.3 0.16
5 O121 162 3.7 0.05
6 O45 114 2.6 0.04
7 O145 112 2.5 0.04
8 O186 42 0.9 <0.01
9 O118 33 0.7 <0.01
10 O69 17 0.4 <0.01
Non-O157, other 
serogroups 161 6.4 0.05
Subtotal, 
all non-O157 2,512 56.6 0.79
Rough* 6 0.1 <0.01
All serogroups 4,437 100.0 1.39
* When isolates are rough, the O group is not expressed and cannot be 
determined by phenotypic methods. These isolates can be O157 or 
non-O157.
Table 1b. Incidence rates of culture-confirmed human 
STEC O157 and non-O157 infections reported to LEDS 




O157 (n = 1,839) Non-O157 (n = 2,396)
Female Male Female Male
<1 1.19 0.69 1.97 2.18
1–4 2.76 3.29 3.66 3.42
5–9 1.22 1.36 0.90 1.04
10–19 0.72 0.82 1.10 1.20
20–29 0.60 0.47 1.19 0.67
30–39 0.31 0.22 0.58 0.31
40–49 0.21 0.13 0.28 0.14
50–59 0.31 0.14 0.38 0.17
60–69 0.39 0.22 0.50 0.27
70–79 0.39 0.30 0.51 0.28
≥80 0.28 0.36 0.50 0.38
Overall 0.59 0.57 0.83 0.67
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Figure 2a. Incidence rate of human Shiga toxin-producing Escherichia coli (STEC) infection reported to LEDS (all 





















































* Includes infections of rough serotype and of unknown serogroup.
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Figure 2b. Incidence rate of culture-confirmed human Shiga toxin-producing Escherichia coli (STEC) O157 
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Figure 2c. Incidence rate of culture-confirmed human Shiga toxin-producing Escherichia coli (STEC) non-O157 
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Figure 2d. Incidence rate of culture-confirmed human Shiga toxin-producing Escherichia coli (STEC) non-O157 
infection, top 5 non-O157 serogroups reported to LEDS, by reporting jurisdiction, United States, 2014
O45 (n = 114)
O111 (n = 501) O121 (n = 162)
O26 (n = 722) O103 (n = 631)
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Figure 4. Percentage of culture-confirmed STEC O157 infections reported to LEDS, by month of specimen 
collection, United States, 2014 and mean annual percentage during 2004–2013 
Figure 5. Percentage of culture-confirmed non-O157 STEC infections reported to LEDS, by month of specimen 
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Other Sources of National Shiga toxin-producing Escherichia coli (STEC) 
Surveillance Data
National Notifiable Diseases Surveillance System (NNDSS)
The National Notifiable Disease Surveillance System (NNDSS) collects and compiles case counts of nationally 
notifiable infectious diseases, including STEC. STEC cases are not currently reported by serogroup to NNDSS.
Annual reports: http://www.cdc.gov/mmwr/mmwr_nd/index.html
Data: https://data.cdc.gov/browse?category=NNDSS
National Antimicrobial Resistance Monitoring System (NARMS)
The National Antimicrobial Resistance Monitoring System (NARMS) Annual Human Isolates Report includes 
antimicrobial resistance data on enteric bacteria (including STEC) isolated from humans.
Annual reports: https://www.cdc.gov/narms/reports/index.html 
Data: https://wwwn.cdc.gov/narmsnow/
National Outbreak Reporting System (NORS)
The National Outbreak Reporting System (NORS) is a web-based platform used by local, state, and territorial 
health departments in the United States to report waterborne and foodborne disease outbreaks and enteric 
disease outbreaks transmitted by contact with environmental sources, infected persons or animals, or 
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Appendix 1. Culture-confirmed Shiga toxin-producing Escherichia coli (STEC) infections reported to LEDS by 
serogroup, age group, and sex, 2014 
Sex 
Serogroup Age Group (years) Female Male Unknown Total
All
<1 61 58 3 122
1–4 500 546 42 1088
5–9 212 252 19 483
10–19 371 432 28 831
20–29 396 260 25 681
30–39 185 111 12 308
40–49 102 57 4 163
50–59 158 68 11 237
60–69 159 79 3 241
70–79 93 50 4 147
≥80 58 33 7 98
Unknown 7 11 20 38
Total 2302 1957 178 4437
Sex 
Serogroup Age Group (years) Female Male Unknown Total
Non-O157
<1 38 44 1 83
1–4 285 278 24 587
5–9 90 109 12 211
10–19 224 255 16 495
20–29 262 153 18 433
30–39 120 65 9 194
40–49 59 29 1 89
50–59 85 37 7 129
60–69 89 43 2 134
70–79 53 24 2 79
≥80 37 17 3 57
Unknown 5 4 12 21
Total 1366 1083 109 2558
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Sex 
Serogroup Age Group (years) Female Male Unknown Total
O157
<1 23 14 2 39
1–4 215 268 18 501
5–9 122 143 7 272
10–19 147 176 12 335
20–29 133 107 7 247
30–39 65 46 3 114
40–49 43 27 3 73
50–59 71 31 4 106
60–69 69 36 1 106
70–79 40 26 2 68
≥80 21 16 4 41
Unknown 2 7 8 17
Total 951 897 71 1919
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Appendix 2a. Culture-confirmed Shiga toxin-producing Escherichia coli (STEC) infections reported to LEDS by 
serogroup and reporting jurisdiction, 2014 (Alaska to Kansas1) 
Serogroup AK AL AR AZ CA CO CT DC DE FL GA HI IA ID IL IN KS
O1 1
O3 1





O26 5 3 36 96 27 8 3 18 17 24 18 4
O28
O45 1 2 1 5 7 3
O50
O55
O69 1 3 1











O91 1 1 1 1
O98 1
O103 6 2 10 47 27 6 1 2 11 31 4 30 2
O105
O110






O118 1 3 2 6 2
O119 1
O121 2 12 9 1 1 5 4 5 1
O128 1
O129
1 The key to state name abbreviations can be found at http://www.census.gov/geo/reference/ansi_statetables.html.
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O186 2 6 5
Rough 1 1
Undetermined1 8 1 1 2
Total 2 30 11 76 550 148 50 5 11 4 86 28 182 89 166 12 37
1 STEC infections reported as “undetermined” are categorized as non-O157 STEC infections.
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Appendix 2b. Culture-confirmed Shiga toxin-producing Escherichia coli (STEC) infections reported to LEDS by 
serogroup and reporting jurisdiction, 2014 (Kentucky to Nevada1)








O26 13 5 5 17 40 28 3 11 1 10 4 11 11 3
O28

















O103 12 6 22 30 33 52 6 2 3 4 7 28 8 1
O105
O110






O118 2 1 4
O119 2
O121 5 11 7 8 2 3 3 1
O128 1
O129
1 The key to state name abbreviations can be found at http://www.census.gov/geo/reference/ansi_statetables.html.
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O145 2 2 2 7 16 2 2 2 1 2 1

















O186 2 4 7 1
Rough 2
Undetermined1 5 1 1 1
Total 63 7 69 96 0 107 280 243 25 40 26 41 9 22 125 38 13
1 STEC infections reported as “undetermined” are categorized as non-O157 STEC infections
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Appendix 2c. Culture-confirmed Shiga toxin-producing Escherichia coli (STEC) infections reported to LEDS by 
serogroup and reporting jurisdiction, 2014 (New York to Wyoming1)
Serogroup NY OH OK OR PA RI SC SD TN TX UT VA VT WA WI WV WY
O1
O3





O26 65 18 23 38 26 3 7 8 1 18 15 53 23 2 1
O28 1
O45 15 10 27 2 2 1 2 9 1
O50 1
O55 1












O91 7 1 1
O98
O103 46 22 13 13 35 4 4 18 1 6 28 17 25 5 1
O105 1
O110 1






O118 4 1 3 2 1 1
O119 1
O121 8 2 4 18 7 1 3 3 10 2 18 6
O128 1
O129 1
1 The key to state name abbreviations can be found at http://www.census.gov/geo/reference/ansi_statetables.html.
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O186 8 1 4 2
Rough 1 1
Undetermined1 2 2 3 1 1
Total 332 148 129 157 207 5 11 54 117 9 71 110 11 190 179 13 3
1 STEC infections reported as “undetermined” are categorized as non-O157 STEC infections.
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Appendix 3. Human Shiga toxin-producing Escherichia coli (STEC) infections reported to LEDS by serogroup and 
year, 2004–2014 
Serogroup 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 Total
O1 1 1 1 1 3 8 2 17
O2 1 1 1 3
O3 3 1 1 5
O4 1 1
O5 3 9 25 20 15 72
O6 1 1 1 1 1 5
O7 2 1 3
O8 1 1 2 5 3 2 3 3 1 21
O9 1 1
O10 1 1




O15 1 1 1 3
O18 1 2 1 4
O19 1 1
O20 1 1
O21 1 2 2 5
O22 1 1 1 1 3 1 8
O23 1 1
O24 1 1
O25 1 1 2
O26 25 53 113 153 222 243 404 605 645 711 722 3896




O38 1 1 2 2 6
O39 1 2 1 4
O42 2 1 1 4
O43 2 1 1 4
O44 1 1
O45 9 13 25 32 65 65 68 135 115 117 114 758
O49 1 4 2 1 8




O55 2 3 2 7
O60 1 1 2
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Serogroup 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 Total
O63 1 1
O68 2 2
O69 4 7 6 15 10 22 26 19 17 126
O70 1 1 2
O71 1 1 3 6 25 15 17 68
O73 1 1 2
O74 1 1 2 3 1 1 9
O75 1 1 2
O76 1 4 4 3 3 9 14 9 7 8 62
O77 1 3 2 5 11
O78 1 1 2
O79 2 1 1 3 2 9
O80 1 5 3 2 2 13
O81 1 1
O82 2 1 1 4




O88 3 1 1 1 1 7
O91 4 3 5 6 8 13 13 18 8 14 92
O93 1 1
O96 1 1 2
O98 1 1 1 2 3 1 9
O100 2 1 3
O101 1 1 2
O103 15 42 81 101 180 233 344 541 557 602 631 3327




O109 2 1 2 5
O110 1 1 1 1 1 3 1 1 1 11
O111 17 30 64 111 241 150 229 316 362 375 501 2396
O112 1 1 1 1 4
O113 1 3 1 2 6 5 5 4 27
O114 1 1
O115 1 1
O116 1 1 1 2 5
O117 1 1 1 1 1 5
O118 1 1 7 4 8 19 22 46 38 20 33 199
O119 3 1 1 2 2 1 1 4 15
O121 8 16 21 58 54 60 67 168 161 148 162 923
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Serogroup 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 Total
O123 1 1 4 3 4 1 14
O124 1 5 2 3 2 6 19
O125 1 3 1 1 3 1 6 16
O126 1 2 2 1 2 3 1 2 5 19
O127 2 2
O128 3 3 4 1 2 3 5 4 3 28
O129 1 1
O130 1 1 1 1 4 2 2 5 1 18
O132 1 1
O134 1 1
O135 1 1 2
O136 1 2 3
O137 1 1 1 3
O140 1 1 2
O141 1 3 1 5
O142 1 1
O143 1 1 1 2 5
O145 5 8 16 19 35 24 72 71 106 63 112 531
O146 2 4 2 6 5 13 2 6 40
O149 1 1
O151 1 2 1 4
O152 1 2 1 1 5
O153 2 5 1 2 3 8 1 2 3 27
O154 1 1
O156 1 4 2 4 2 2 4 2 5 26
O157 2107 2205 2877 2338 2637 2206 1969 2343 2449 2230 1919 25280
O158 1 1 1 1 4
O159 1 4 5
O160 1 1
O162 1 2 1 4
O163 1 2 2 2 1 1 2 11
O164 1 1
O165 1 8 5 5 4 6 6 11 9 6 61
O166 1 3 1 5
O168 1 1 2
O169 1 1
O171 1 1 2
O172 1 1 2 3 1 2 3 13
O174 2 3 2 2 1 6 4 6 1 27
O175 1 1 2 1 1 6
O177 3 3 1 2 2 4 4 5 3 27
O178 2 4 1 3 2 4 5 1 22
O179 4 1 2 7
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Serogroup 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 Total
O181 2 4 2 8 5 5 26
O182 1 1 2
O183 1 1 2
O185 1 1
O186 4 27 30 42 103
Rough 1 15 8 29 40 42 76 79 35 71 6 402
Undetermined1 4 8 7 10 29 58
Unknown 48 73 160 466 443 429 782 916 1174 781 999 6271
Total 2245 2480 3434 3401 3999 3557 4169 5422 5909 5353 5436 45405
1 STEC infections reported as “undetermined” are categorized as non-O157 STEC infections.
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